Asplenia means the absence of a spleen. Asplenia can occur in a variety of clinical settings, and it can refer to an anatomic absence of the spleen or functional asplenia secondary to a variety of disease states. The spleen is one of the primary extramedullary lymphoid organs. It is located in the left upper quadrant of the abdomen. Normally, the spleen is not palpable on physical exam and measures on average 10.65 by 5.16 cm. Normal spleen size can vary by gender and race. For example, men on average have larger spleens than females, and Caucasians, on average, tend to have larger spleens compared to African American individuals. When palpable or notably enlarged on imaging, the clinician must consider a variety of underlying disease states (whether acquired or inherited) contributing to the enlargement.
Functionally, the spleen’s primary physiologic role is the filtration and processing of senescent blood cells (predominantly red blood cells or RBCs) and immunologically helps protect against encapsulated microorganisms and response to infectious pathogens. It contains both hematopoietic and lymphopoietic elements, providing a basis for extramedullary hematopoiesis when necessary. The spleen has two functionally and histologically distinct tissues where these processes take place: the white pulp and the red pulp. The white pulp has a large mass of lymphoid tissue that produces antibodies against recognized antigens, whereas the red pulp has a tight network of sinusoids called the cord of Billroth which helps in blood filtration. As the body's largest filter of blood, it helps to remove old RBCs from the circulation aiding in the removal of bloodborne microorganisms. Beyond the spleen, the lymphatic system of the body consists of a complex myriad of lymphatic vessels, lymph nodes, and other specific extramedullary lymphoid organs including the thymus, tonsils, and appendix, which collectively play a very important role in immune defenses.
Asplenia can be caused by damage to the white pulp, the red pulp or both. The spleen is a direct and indirect site of potential toxicity that can secondarily arise from underlying disease processes or infection. One must understand and appreciate the various etiologies and potential complications of asplenia, such as being a great risk factor for encapsulated microorganisms. Bacterial infections with Neisseria meningitides or Streptococcal pneumoniae, among many others, can become life-threatening if untreated in patients with anatomic or functional asplenia. Patients without a spleen have a 200-fold greater risk of death from septicemia compared to those with an adequate functioning spleen. There are many case reports in the medical literature reporting of asplenic patients, unfortunately, succumbing to infectious disease leading to death. One notable example reported by Heubner ML et al. (2015) described the rare case of a patient who had required splenectomy due to refractory immune thrombocytopenia (ITP). He subsequently developed a pneumococcal meningitis infection and died despite best supportive efforts. The rate of invasive bacterial infection and mortality in asplenic patients is significantly higher compared to normal controls – 69% in meningitis, 64% in septicemia, and 7% in Purpura fulminans.
Asplenia can be acquired, functionally reduced despite its anatomic presence, or in those who congenitally lack a spleen at birth. Most commonly, acquired asplenia is due to surgical removal or trauma. According to a survey by the National Hospital Discharge Survey in the United States done in 2005, approximately 22,000 splenectomies were performed. The most common indication for splenectomy was due to preceding trauma. According to a retrospective study that reviewed the historic clinical indications for splenectomy, traumatic injury accounted for more than 41.5%; hematologic malignancy accounted for 15.4%, and cytopenias accounted for 15.4% of all splenectomies performed.
A variety of benign and malignant hematologic disorders can result in the potential need for splenectomy. Some examples include hereditary spherocytosis, sickle cell disease, thalassemia major or intermedia, refractory immune thrombocytopenia (ITP), myeloproliferative disorders (e.g., severe or symptomatic splenomegaly in myelofibrosis), certain types of autoimmune hemolytic anemias, lymphoproliferative disorders, and rarely in thrombotic thrombocytopenic purpura (TTP).
Congenital asplenia may be isolated or as a clinical sequela of broader (albeit rare) clinical syndromes such as Ivemark syndrome. This syndrome is classified under heterotaxy syndrome. It is associated with asplenia or hypoplasia of the spleen, malformation of the heart and abnormal arrangements of organs of the chest and abdomen.
In addition to the more common causes of asplenia, many other etiologies have been described in the literature affecting various body systems as listed below.
The epidemiology of asplenia differs depending on its etiology. Nearly 100% of sickle cell anemia patients (i.e., those with hemoglobin SS disease) will develop asplenia, and they are prone to overwhelming post-splenectomy infection. Many other patients with similar hemoglobinopathies are at risk of splenomegaly and a possible need for splenectomy or may develop functional asplenia with the course of their disease (e.g., hemoglobin SC disease).
Other diseases associated with reduced function of the spleen include celiac disease, with an estimated prevalence of 33% to 76%, Whipple disease is 47%, and alcoholic liver disease is 37% to 100%.
Remark syndrome is seen in 1 in 10,000 to 40,000 of cases.
The pathophysiology of asplenia also varies depending on the underlying etiology and comorbid conditions. In many benign hematologic disorders, for example, functional asplenia is caused by persistent and recurrent hyper sequestration of red blood cells (RBCs) leading to RBC entrapment. This entrapment leads to splenic enlargement and then later atrophy. Profound atrophy of the spleen is also known as autosplenectomy. Autosplenectomy is usually seen in sickle cell anemia patients, especially those with HgbSS disease. In hematologic malignancies, by contrast, asplenia may result from direct infiltration of the malignant cells into the parenchyma of the spleen.
Many GI disorders can lead to functional asplenia. For example, in cases of hepatic dysfunction or failure, asplenia can develop due to the disruption of the normal hepatic circulation, such as in portal hypertension. Alcohol consumption has been known to cause a direct toxic effect on splenic tissue.  In other disorders like Celiac disease, asplenia is caused by excessive loss of lymphocytes through inflamed enteric mucosa, leading to reticuloendothelial atrophy.
Histologically, atrophy of the spleen is evident by degeneration of white pulp (i.e., decreased periarteriolar lymphatic sheaths, or PALS, decreased follicles, germinal centers, and marginal zones). Decreased amounts of hematopoietic components characterize red pulp atrophy.
Cytologically, the presence of Howell-Jolly bodies and pitted red blood cells visible upon review of a peripheral blood smear may be suggestive of asplenia or reduced function of the spleen. Other non-specific cytologic findings include absolute monocytosis, lymphocytosis, and/or thrombocytosis.
Patients with asplenia can be asymptomatic, while some can present with malaise, fatigue, fever, and/or encephalopathy. On physical examination, a normal spleen is not palpable. When enlarged, it can typically be palpated below the costophrenic border on deep inspiration. In patients with various degrees of functional asplenia (autosplenectomy), the spleen will usually not be palpable due to chronic atrophy.
Patients may also present with signs or symptoms indicative of underlying infection. Severe infection due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitides are the most common bacterial infections recognized in these patients. As such, it is important to assess for nuchal rigidity in these patients if they present with fever. In particular, pneumococcal meningitis can be up to four times more fatal in asplenic patients compared to other forms of bacterial meningitis, and over six times more likely to result in poor health outcomes.
As noted, analysis of the peripheral blood smear may demonstrate the presence of Howell-Jolly bodies providing the clinician with a clue of underlying splenic dysfunction (e.g., congenital or functional asplenia). To confirm physical exam findings and establish the anatomic presence (or absence) and measurement of the spleen various imaging modalities can be utilized including abdominal ultrasound (US), CT, MRI, or spleen scintigraphy. Using ultrasonography, CT or MRI of the abdomen may also help in better characterization of possible congenital or vascular abnormalities. Spleen scintigraphy is a specialized imaging modality using a 99-Tc labeled radio colloid that is specific for splenic tissue; a lack of uptake signifies asplenia.
As noted, patients with asplenia are at a significantly increased risk of severe bacterial infection, especially from encapsulated microorganisms. As a result, efforts have been made over the last decade to improve the prevention, early detection, and management of infections encountered in asplenic patients. The most common bacterial pathogen leading to infection in patients with asplenia is Streptococcus pneumoniae. According to one study by Waghorn et al., up to 87% of asplenic patients were found to have been infected with Strep. pneumoniae. To avoid morbidity, regardless of the cause of their asplenia, all patients should be counseled to receive vaccinations against these encapsulated bacteria. Vaccinations are recommended before splenectomy and after the surgical removal. For those with functional asplenia (or autosplenectomy), it is also advised to continue aggressive vaccination schedules. Before planned surgery for splenectomy, it is recommended that patients receive the pneumococcal conjugate vaccine (PCV-13) 8 weeks in advance, as well as the pneumococcal polysaccharide vaccine (PPSV-23), Haemophilus influenzae type B vaccine (Hib), and the quadrivalent meningococcal conjugate vaccine 14 days before surgery.
Vaccination must continue in the post-operative period, and 5 years after the surgery it is recommended that patients receive the PPSV-23 and then again at age 65. The meningococcal conjugate vaccine should be repeated every 5 years. For those with acquired immunodeficiency, it may be advisable to check for titers to determine immune status. Apart from all these vaccines, patients should be encouraged to receive annual vaccination against the common strains of influenza. It has been recommended that prophylactic penicillin be considered in children with asplenia (e.g., patients with sickle cell disease) until the age of 5, although this prophylaxis is not recommended in adults. Asplenic adults, however, should have antibiotics readily available via their health care provider for use if they develop signs of infection as any delay in antibiotic access may be detrimental.
Overwhelming post-splenectomy infection is common especially in children younger than 16 years old due to their immune immaturity. Patients with asplenia who present with signs of infection should be immediately started on broad-spectrum antibiotics until further testing can isolate the causative microorganism. According to the Surviving Sepsis Campaign guidelines, patients suspected of sepsis should be started on antibiotics within 1 hour to avoid poor outcome. Aggressive intravenous (IV) hydration should also be promptly initiated as per standard sepsis guidelines and as part of supportive care. Since asplenic patients are prone to developing septic shock, they may also require vasopressors to maintain their blood pressure. In certain circumstances, mechanical ventilation may be necessary if patients develop respiratory failure.
The differential diagnosis of asplenia includes hyposplenia. Hyposplenia shares many of the clinical features as asplenia and may precede further functional decline or autosplenectomy. Unlike asplenia, hyposplenia may be reversible if the underlying condition is treated. For instance, in patients with Celiac disease who develop hyposplenia, the spleen can return to normal function if the Celiac disease is better controlled.
The prognosis of asplenia is poor if left unrecognized, as patients will be at higher risk of infection without proper vaccination. Antibiotic prophylaxis and vaccinations are the recommended management in many asplenic patients and those with acquired immunodeficiency and asplenia. As noted, patients who do not receive immunizations are at high risk of severe bacterial infection, sepsis, septic shock, and death. One case report by Huebner and colleagues provides evidence of the poor prognosis in asplenic patients who succumb to infection despite receiving standard medical care. This case described a 45-year-old man with a history of splenectomy during childhood who presented with high fevers. He was found to have pneumococcal meningitis and was appropriately started on antibiotics and fluid resuscitation, though unfortunately his clinical status deteriorated quickly and was pronounced dead from sepsis. Many such illustrative cases and case series are reported in the medical literature.
The most common medical complication in asplenic patients is an overwhelming post-splenectomy infection (OPSI). As noted, asplenic patients are at higher risk of infection with encapsulated microorganisms (e.g., streptococcal pneumonia). According to Kirkineska and colleagues, OPSI results in massive bacteremia caused by encapsulated microorganisms. The primary source of infection is not commonly identified, there is a short prodromal phase, and septic shock occasionally associated with disseminated intravascular coagulopathy (DIC) can occur. Up to 60% to 70% mortality rate has been observed in patients with OPSI if not appropriately managed.
In a normal functioning spleen, the red pulp filters blood and removes old red blood cells; it causes phagocytosis of infected erythrocytes which helps to form a defense against intraerythrocytic parasites. Parasitic infections such as babesiosis and malaria are common in patients with asplenia due to loss of phagocytosis.
The white pulp of the spleen has both T-cell and B-cell compartments which help with adaptive immunity and antibody production. The spleen provides the largest B cells which help in humoral immune response. The lack of memory B cells in the asplenic patient causes severe illness compared to the general population.
Because the spleen functions as a reservoir for non-circulation and undifferentiated monocytes, splenectomy causes lack of this reserve. According to Swirski et al., these undifferentiated monocytes stored in clusters in the red pulp, respond to myocardial injury and help in wound healing.
Apart from its role in immunity, the spleen also has a role in vascular and thrombotic complications. Vascular complications were also observed mostly in patients with hematologic diseases like beta-thalassemia. In a survey done by Taher et al., they found that in patients with asplenia due to beta thalassemia, the prevalence of thrombotic event was 1.65%. There have also been increased incidences of stroke, myocardial infarction, and CAD in these patients. These vascular complications could be due to chronic inflammation and dysfunction of the endothelium. The destruction of the endothelial lining could lead to platelet activation and thrombosis.
Due to the risk of thrombosis in asplenic, patient another complication reported in pulmonary hypertension. According to Hoeper et al., the incidence of pulmonary hypertension in asplenia patient is 8% to 11.5%, and numbers are even higher in patients with hemoglobinopathies. In patients with sickle cell or beta-thalassemia, the incidence could be as high 30%.
Patients also can develop adrenal hemorrhage also known as Waterhouse-Friedrichsen syndrome and Purpura fulminans. These two conditions require a high index of suspicion by the treating clinician. Early recognition and management are critical to avoid morbidity and mortality.
The primary goal in all asplenic patients is to provide adequate preventive medicine. Patients with asplenia need to understand the complications involved, especially the risk of serious infection which can result in premature death. Vaccinations and use of prophylactic antibiotics (in certain clinical circumstances) need to be emphasized. Specifically, patients with asplenia should be up to date on their pneumococcus, meningitis, Haemophilus, and influenza vaccinations. Recommended prophylactic antibiotics typically include amoxicillin and penicillin. In certain contexts (e.g., young children with asplenia or immunocompromised adults) patients must be educated on the proper use of prophylactic antibiotics. Patients who are traveling to areas of the world with endemic parasitic pathogens (e.g., malaria, Babesia) should also be educated about their increased risk of infection with these intraerythrocytic parasites. Anti-malarial prophylaxis or other prophylactic antimicrobials may be indicated depending on the region of the world and endemic pathogens present.
The three most common causes of splenectomy include traumatic, neoplastic, and hematologic. Given the beneficial role the spleen has in immunity, surgical protocols have evolved with efforts to preserve the spleen during emergency surgical operations for trauma patients. Furthermore, alternative, non-surgical interventions for splenic trauma are being increasingly implemented. According to an 8-year study by Rosati et al., there is an increase in non-surgical management of splenic trauma because of the increased use of angiographic embolization. The spleen has increasingly been recognized as a vital organ. Preserving the spleen will promote a healthy immune system, and the infectious and thromboembolic complications often seen in asplenic patients can be avoided. For patients with hematologic etiologies responsible for their functional asplenia and who are prone to have autosplenectomy, their vaccinations should be up to date. Physicians and other healthcare professionals should frequently reassess vaccinations during each follow-up visit.
|||Hosey RG,Mattacola CG,Kriss V,Armsey T,Quarles JD,Jagger J, Ultrasound assessment of spleen size in collegiate athletes. British journal of sports medicine. 2006 Mar [PubMed PMID: 16505083]|
|||Suttie AW, Histopathology of the spleen. Toxicologic pathology. 2006; [PubMed PMID: 17067940]|
|||Crary SE,Buchanan GR, Vascular complications after splenectomy for hematologic disorders. Blood. 2009 Oct 1; [PubMed PMID: 19636061]|
|||Mebius RE,Kraal G, Structure and function of the spleen. Nature reviews. Immunology. 2005 Aug; [PubMed PMID: 16056254]|
|||Erdem SB,Genel F,Erdur B,Ozbek E,Gulez N,Mese T, Asplenia in children with congenital heart disease as a cause of poor outcome. Central-European journal of immunology. 2015; [PubMed PMID: 26557043]|
|||Huebner ML,Milota KA, Asplenia and fever. Proceedings (Baylor University. Medical Center). 2015 Jul; [PubMed PMID: 26130882]|
|||DeFrances CJ,Cullen KA,Kozak LJ, National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data. Vital and health statistics. Series 13, Data from the National Health Survey. 2007 Dec; [PubMed PMID: 18350768]|
|||Rose AT,Newman MI,Debelak J,Pinson CW,Morris JA Jr,Harley DD,Chapman WC, The incidence of splenectomy is decreasing: lessons learned from trauma experience. The American surgeon. 2000 May; [PubMed PMID: 10824750]|
|||Masiwal P,Chenthil KS,Priyadarsini B,Gnanaprakasam J,Srihari I, Ivemark Syndrome. The Journal of the Association of Physicians of India. 2016 May; [PubMed PMID: 27735157]|
|||Kirkineska L,Perifanis V,Vasiliadis T, Functional hyposplenism. Hippokratia. 2014 Jan; [PubMed PMID: 25125944]|
|||William BM,Corazza GR, Hyposplenism: a comprehensive review. Part I: basic concepts and causes. Hematology (Amsterdam, Netherlands). 2007 Feb; [PubMed PMID: 17364987]|
|||Waghorn DJ, Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. Journal of clinical pathology. 2001 Mar; [PubMed PMID: 11253134]|
|||Rubin LG,Schaffner W, Clinical practice. Care of the asplenic patient. The New England journal of medicine. 2014 Jul 24; [PubMed PMID: 25054718]|
|||Rhodes A,Evans LE,Alhazzani W,Levy MM,Antonelli M,Ferrer R,Kumar A,Sevransky JE,Sprung CL,Nunnally ME,Rochwerg B,Rubenfeld GD,Angus DC,Annane D,Beale RJ,Bellinghan GJ,Bernard GR,Chiche JD,Coopersmith C,De Backer DP,French CJ,Fujishima S,Gerlach H,Hidalgo JL,Hollenberg SM,Jones AE,Karnad DR,Kleinpell RM,Koh Y,Lisboa TC,Machado FR,Marini JJ,Marshall JC,Mazuski JE,McIntyre LA,McLean AS,Mehta S,Moreno RP,Myburgh J,Navalesi P,Nishida O,Osborn TM,Perner A,Plunkett CM,Ranieri M,Schorr CA,Seckel MA,Seymour CW,Shieh L,Shukri KA,Simpson SQ,Singer M,Thompson BT,Townsend SR,Van der Poll T,Vincent JL,Wiersinga WJ,Zimmerman JL,Dellinger RP, Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive care medicine. 2017 Mar; [PubMed PMID: 28101605]|
|||O'Neal HR Jr,Niven AS,Karam GH, Critical Illness in Patients With Asplenia. Chest. 2016 Dec; [PubMed PMID: 27068019]|
|||Swirski FK,Nahrendorf M,Etzrodt M,Wildgruber M,Cortez-Retamozo V,Panizzi P,Figueiredo JL,Kohler RH,Chudnovskiy A,Waterman P,Aikawa E,Mempel TR,Libby P,Weissleder R,Pittet MJ, Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (New York, N.Y.). 2009 Jul 31; [PubMed PMID: 19644120]|
|||Taher A,Isma'eel H,Mehio G,Bignamini D,Kattamis A,Rachmilewitz EA,Cappellini MD, Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thrombosis and haemostasis. 2006 Oct; [PubMed PMID: 17003927]|
|||Schilling RF, Spherocytosis, splenectomy, strokes, and heat attacks. Lancet (London, England). 1997 Dec 6; [PubMed PMID: 9400518]|
|||Phrommintikul A,Sukonthasarn A,Kanjanavanit R,Nawarawong W, Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia. Heart (British Cardiac Society). 2006 Oct; [PubMed PMID: 16621878]|
|||Hale AJ,LaSalvia M,Kirby JE,Kimball A,Baden R, Fatal purpura fulminans and Waterhouse-Friderichsen syndrome from fulminant Streptococcus pneumoniae sepsis in an asplenic young adult. IDCases. 2016; [PubMed PMID: 27583208]|
|||Katz SC,Pachter HL, Indications for splenectomy. The American surgeon. 2006 Jul; [PubMed PMID: 16875077]|
|||Rosati C,Ata A,Siskin GP,Megna D,Bonville DJ,Stain SC, Management of splenic trauma: a single institution's 8-year experience. American journal of surgery. 2015 Feb; [PubMed PMID: 25457232]|